dc.contributor.author | Arvas, M | |
dc.contributor.author | Kose, K | |
dc.contributor.author | Ortac, F | |
dc.contributor.author | Kosebay, D | |
dc.contributor.author | Sonmezer, M | |
dc.contributor.author | Gungor, M | |
dc.date.accessioned | 2021-03-05T17:35:45Z | |
dc.date.available | 2021-03-05T17:35:45Z | |
dc.date.issued | 2005 | |
dc.identifier.citation | Gungor M., Ortac F., Arvas M., Kosebay D., Sonmezer M., Kose K., "The role of secondary cytoreductive surgery for recurrent ovarian cancer", GYNECOLOGIC ONCOLOGY, cilt.97, ss.74-79, 2005 | |
dc.identifier.issn | 0090-8258 | |
dc.identifier.other | av_c64eb161-b2c8-4f95-b992-9fd4dee2d8c6 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/131472 | |
dc.identifier.uri | https://doi.org/10.1016/j.ygyno.2004.11.057 | |
dc.description.abstract | Objective. The aim of this study was to assess the survival benefit of salvage surgical cytoreduction in patients with recurrent ovarian cancer and compare the surgical outcorne with salvage chemotherapy alone. | |
dc.language.iso | eng | |
dc.subject | Onkoloji | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Kadın Hastalıkları ve Doğum | |
dc.subject | Sağlık Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | KADIN HASTALIKLARI & DOĞUM | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | The role of secondary cytoreductive surgery for recurrent ovarian cancer | |
dc.type | Makale | |
dc.relation.journal | GYNECOLOGIC ONCOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 97 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 74 | |
dc.identifier.endpage | 79 | |
dc.contributor.firstauthorID | 174932 | |